Yahoo Search Busca da Web

Resultado da Busca

  1. 182. 2015. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. K Bieganowska, P Höllsberg, GJ Buckle, DG Lim, TF Greten, J Schneck, ... The Journal of Immunology 162 (3), 1765-1771.

  2. For information more information and positions available please contact Jonathan Schneck. Dr. Jonathan Schneck was recently awarded an Innovative Molecular Analysis Technologies (IMAT) grant from the National Institutes of Health/National Cancer Institutes.

  3. Jonathan Schneck (Professor of Pathology, Medicine and Oncology) received his M.D. Ph.D. in Immunology from the Albert Einstein College of Medicine. After completing his degree, Dr. Schneck trained in Pediatrics at the Children’s Hospital National Medical Center in Washington DC.

  4. Dr. Schneck is a world-renowned leader in the fields of cellular immunology and immunoengineering. As senior JHU faculty, Dr. Schneck has led multiple scientific and educational programs, including the largest NIAID funded basic immunology P01 awarded to JHMI, and was course director of the JHSOM GTS-immunology for over two decades.

  5. Dr. Jonathan Schneck is a world-renowned leader in the fields of cellular immunology and immunoengineering. As senior JHU faculty, Dr. Schneck has led multiple scientific and educational programs, including the largest NIAID funded basic immunology PO1 awarded to JHMI and course director of the JHU SOM GTS-immunology.

  6. Dr. Jonathan Schneck is a Professor of Pathology, Medicine and Oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on T cell immunology.

  7. Dr. Jonathan Schneck is a Professor of Pathology, Medicine and Oncology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on T cell immunology.